Value of the Combined Test in Prenatal Diagnostics

Ebrahim S, Daponte A, Guidozzi F. The impact of free antenatal care on perinatal mortality. Int J Gynaecol Obstet. 2000; 71(3): 205-207.10.1016/S0020-7292(00)00212-5Search in Google Scholar

Alfirevic Z, Neilson JP. Antenatal screening for Down's syndrome. Br Med J. 2004; 329(7470): 811-812.10.1136/bmj.329.7470.811Search in Google Scholar

Spencer K. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum βhCG and PAPP-A. Br J Obstet Gynaecol. 2001; 108: 1043-1046.Search in Google Scholar

Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med. 1999; 341(7): 461-467.10.1056/NEJM199908123410701Search in Google Scholar

Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen. 2003; 10(2): 56-104. (Erratum in: J Med Screen. 2006; 13(1): 51-52.)10.1177/096914130301000202Search in Google Scholar

Stojilkovic-Mikic T, Rodeck CH. Screening for chromosomal anomalies: first or second trimester, biochemical or ultrasound? Ann Acad Med Singapore. 2003; 32(4): 583-589.Search in Google Scholar

Haddow JE, Palomaki GE, Knight GJ, Williams J, Miller WA, Johnson A. Screening of maternal serum for fetal Down's syndrome in the first trimester. N Engl J Med. 1998; 338(14): 955-961.10.1056/NEJM199804023381404Search in Google Scholar

Wald NJ, George L, Smith D, Densem JW, Petterson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. Br J Obstet Gynaecol. 1996; 103(5): 407-412.10.1111/j.1471-0528.1996.tb09765.xSearch in Google Scholar

Snijders RJM, Farrias M, Kaisenberg C, Nicolaides KH. Fetal abnormalities. In: Sniijders RJM, Nicolaides KH, Eds. Ultrasound Markers for Fetal Chromosomal Defects. New York: Parthenon, 1996: 1-63.Search in Google Scholar

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap L, Wenstrom KD, Eds. Prenatal diagnosis and fetal therapy. Williams Obstetrics. New York: McGraw-Hill, 2005: 313-340.Search in Google Scholar

Wellesley D, Boyle T, Barber J, Howe DT. Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region. Br Med J. 2002; 325(7354): 15-17.10.1136/bmj.325.7354.15Search in Google Scholar

Lončar D, Varjačić M, Novaković T, Milovanović D, Janković S. Correlation between serum biochemical markers and early amniocentesis in diagnosis of congenital fetal anomalies. Bosnian J Basic Med Sci. 2010; 10(1): 9-14.10.17305/bjbms.2010.2726Search in Google Scholar

Hallahan T, Krantz D, Orlandi F, Rossi C, Curcio P, Macri S, Larsen J, Buchanan P, Macri J. First trimester biochemical screening for Down syndrome: free β-hCG versus intact hCG. Prenat Diagn. 2000; 20(10): 785-789.10.1002/1097-0223(200010)20:10<785::AID-PD892>3.0.CO;2-6Search in Google Scholar

Brigatti KW, Malone FD. First trimester screening for aneuploidy. Obstet Gynecol Clin North Am. 2004; 31(1): 1-20.10.1016/S0889-8545(03)00119-0Search in Google Scholar

Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004; 191(1): 45-67.10.1016/j.ajog.2004.03.09015295343Search in Google Scholar

Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 1999; 13(4): 231-237.10.1046/j.1469-0705.1999.13040231.x10341399Search in Google Scholar

Krantz DA, Hallahan TW, Orlandi F, Buchanan P, Larsen JW Jr, Macri JN. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol. 2000; 96(2): 207-213.Search in Google Scholar

Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol. 2000; 107(10): 1271-1275.10.1111/j.1471-0528.2000.tb11619.x11028580Search in Google Scholar